Cargando…

Smoking cessation among diabetes patients: results of a pilot randomized controlled trial in Kerala, India

BACKGROUND: India has the second largest diabetic population (61 million) and tobacco users (275 million) in the world. Data on smoking cessation among diabetic patients are limited in low and middle income countries. The objective of the study was to document the effectiveness of diabetic specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Thankappan, KR, Mini, GK, Daivadanam, Meena, Vijayakumar, G, Sarma, PS, Nichter, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560246/
https://www.ncbi.nlm.nih.gov/pubmed/23331722
http://dx.doi.org/10.1186/1471-2458-13-47
_version_ 1782257767142129664
author Thankappan, KR
Mini, GK
Daivadanam, Meena
Vijayakumar, G
Sarma, PS
Nichter, Mark
author_facet Thankappan, KR
Mini, GK
Daivadanam, Meena
Vijayakumar, G
Sarma, PS
Nichter, Mark
author_sort Thankappan, KR
collection PubMed
description BACKGROUND: India has the second largest diabetic population (61 million) and tobacco users (275 million) in the world. Data on smoking cessation among diabetic patients are limited in low and middle income countries. The objective of the study was to document the effectiveness of diabetic specific smoking cessation counseling by a non-doctor health professional in addition to a cessation advice to quit, delivered by doctors. METHODS: In our parallel-group randomized controlled trial, we selected 224 adult diabetes patients aged 18 years or older who smoked in the last month, from two diabetes clinics in South India. Using a computer generated random sequence with block size four; the patients were randomized equally into intervention-1 and intervention-2 groups. Patients in both groups were asked and advised to quit smoking by a doctor and distributed diabetes specific education materials. The intervention-2 group received an additional diabetes specific 30 minutes counseling session using the 5As (Ask, Advise, Assess, Assist and Arrange), and 5 Rs (Relevance, Risks, Rewards, Roadblocks and Repetition) from a non-doctor health professional. Follow up data were available for 87.5% of patients at six months. The Quit Tobacco International Project is supported by a grant from the Fogarty International Centre of the US National Institutes of Health (RO1TW005969-01). The primary outcomes were quit rate (seven day smoking abstinence) and harm reduction (reduction of the number of cigarettes / bidis smoked per day > 50% of baseline use) at six months. RESULTS: In the intention to treat analysis, the odds for quitting was 8.4 [95% confidence interval (CI): 4.1-17.1] for intervention-2 group compared to intervention-1 group. Even among high level smokers the odds of quitting was similar. The odds of harm reduction was 1.9 (CI: 0.8-4.1) for intervention-2 group compared to intervention-1 group. CONCLUSIONS: The value addition of culturally sensitive diabetic specific cessation counseling sessions delivered by non-doctor health professional was an impressive and efficacious way of preventing smoking related diabetic complications. TRIAL REGISTRATION: Clinical Trial Registry of India (CTRI/2012/01/002327)
format Online
Article
Text
id pubmed-3560246
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35602462013-02-04 Smoking cessation among diabetes patients: results of a pilot randomized controlled trial in Kerala, India Thankappan, KR Mini, GK Daivadanam, Meena Vijayakumar, G Sarma, PS Nichter, Mark BMC Public Health Research Article BACKGROUND: India has the second largest diabetic population (61 million) and tobacco users (275 million) in the world. Data on smoking cessation among diabetic patients are limited in low and middle income countries. The objective of the study was to document the effectiveness of diabetic specific smoking cessation counseling by a non-doctor health professional in addition to a cessation advice to quit, delivered by doctors. METHODS: In our parallel-group randomized controlled trial, we selected 224 adult diabetes patients aged 18 years or older who smoked in the last month, from two diabetes clinics in South India. Using a computer generated random sequence with block size four; the patients were randomized equally into intervention-1 and intervention-2 groups. Patients in both groups were asked and advised to quit smoking by a doctor and distributed diabetes specific education materials. The intervention-2 group received an additional diabetes specific 30 minutes counseling session using the 5As (Ask, Advise, Assess, Assist and Arrange), and 5 Rs (Relevance, Risks, Rewards, Roadblocks and Repetition) from a non-doctor health professional. Follow up data were available for 87.5% of patients at six months. The Quit Tobacco International Project is supported by a grant from the Fogarty International Centre of the US National Institutes of Health (RO1TW005969-01). The primary outcomes were quit rate (seven day smoking abstinence) and harm reduction (reduction of the number of cigarettes / bidis smoked per day > 50% of baseline use) at six months. RESULTS: In the intention to treat analysis, the odds for quitting was 8.4 [95% confidence interval (CI): 4.1-17.1] for intervention-2 group compared to intervention-1 group. Even among high level smokers the odds of quitting was similar. The odds of harm reduction was 1.9 (CI: 0.8-4.1) for intervention-2 group compared to intervention-1 group. CONCLUSIONS: The value addition of culturally sensitive diabetic specific cessation counseling sessions delivered by non-doctor health professional was an impressive and efficacious way of preventing smoking related diabetic complications. TRIAL REGISTRATION: Clinical Trial Registry of India (CTRI/2012/01/002327) BioMed Central 2013-01-18 /pmc/articles/PMC3560246/ /pubmed/23331722 http://dx.doi.org/10.1186/1471-2458-13-47 Text en Copyright ©2013 Thankappan et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Thankappan, KR
Mini, GK
Daivadanam, Meena
Vijayakumar, G
Sarma, PS
Nichter, Mark
Smoking cessation among diabetes patients: results of a pilot randomized controlled trial in Kerala, India
title Smoking cessation among diabetes patients: results of a pilot randomized controlled trial in Kerala, India
title_full Smoking cessation among diabetes patients: results of a pilot randomized controlled trial in Kerala, India
title_fullStr Smoking cessation among diabetes patients: results of a pilot randomized controlled trial in Kerala, India
title_full_unstemmed Smoking cessation among diabetes patients: results of a pilot randomized controlled trial in Kerala, India
title_short Smoking cessation among diabetes patients: results of a pilot randomized controlled trial in Kerala, India
title_sort smoking cessation among diabetes patients: results of a pilot randomized controlled trial in kerala, india
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560246/
https://www.ncbi.nlm.nih.gov/pubmed/23331722
http://dx.doi.org/10.1186/1471-2458-13-47
work_keys_str_mv AT thankappankr smokingcessationamongdiabetespatientsresultsofapilotrandomizedcontrolledtrialinkeralaindia
AT minigk smokingcessationamongdiabetespatientsresultsofapilotrandomizedcontrolledtrialinkeralaindia
AT daivadanammeena smokingcessationamongdiabetespatientsresultsofapilotrandomizedcontrolledtrialinkeralaindia
AT vijayakumarg smokingcessationamongdiabetespatientsresultsofapilotrandomizedcontrolledtrialinkeralaindia
AT sarmaps smokingcessationamongdiabetespatientsresultsofapilotrandomizedcontrolledtrialinkeralaindia
AT nichtermark smokingcessationamongdiabetespatientsresultsofapilotrandomizedcontrolledtrialinkeralaindia